BMO initiates with $455 target, RBC downgrades on technicals, ARK buys $20.5M shares. AI revenue surges 143% to $10.8B, but ...

The timing could hardly be more awkward — or more opportune. IREN steps into the earnings spotlight on the very day the entire AI infrastructure complex is bask ...

The market's romance with BioNTech has been building for weeks, fueled by a leadership handover, a sympathetic rally from ...

The disconnect between Rocket Lab's operational momentum and its share price has rarely been starker. While the company ...

The timing could hardly be more awkward. Just as Lufthansa rolls out free Starlink satellite Wi-Fi on its first commercial ...

Azure crosses $100B revenue, but hidden profitability, rising costs, and free cash flow decline raise concerns about AI spending efficiency.

The Munich-based insurer finds itself in an unusual position: momentum is on its side, yet the market's most cautious voices are starting to ask how much furthe ...

Nvidia faces a pivotal earnings report amid a $6B licensing deal, Taiwan export indictment, and expected revenue of $92.2B—options imply a $280B market value swing.

The quiet resolution of a cross-border arbitration dispute has removed a lingering overhang from Sellas Life Sciences, even as the biotech's share price continu ...

Two of Wienerberger's most senior figures have quietly added to their stakes in the brick-and-pipe maker within the space of a fortnight, a show of faith that s ...

Ethereum's recent recovery has exposed a striking disconnect beneath the surface. While retail investors holding between 100 ...

The tank gearbox specialist Renk Group finds itself at an unusual crossroads. Its order books are bulging, analysts are ...